The United Laboratories International Holdings Limited (3933.HK)

HKD 13.94

(0.29%)

Inventory Summary of The United Laboratories International Holdings Limited

The United Laboratories International Holdings Limited's latest annual inventory in 2023 was 2.23 Billion CNY , up 3.46% from previous year.
The United Laboratories International Holdings Limited's latest quarterly inventory in 2024 Q2 was 2.37 Billion CNY , down 0.0% from previous quarter.
The United Laboratories International Holdings Limited reported annual inventory of 2.16 Billion CNY in 2022, up 7.96% from previous year.
The United Laboratories International Holdings Limited reported annual inventory of 2 Billion CNY in 2021, up 40.29% from previous year.
The United Laboratories International Holdings Limited reported quarterly inventory of 2.19 Billion CNY for 2023 Q2, down 0.0% from previous quarter.
The United Laboratories International Holdings Limited reported quarterly inventory of 2.23 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of The United Laboratories International Holdings Limited (2023 - 2006)

Historical Annual Inventory of The United Laboratories International Holdings Limited (2023 - 2006)

Year	Inventory	Inventory Growth
2023	2.23 Billion CNY	3.46%
2022	2.16 Billion CNY	7.96%
2021	2 Billion CNY	40.29%
2020	1.42 Billion CNY	-9.31%
2019	1.57 Billion CNY	7.55%
2018	1.46 Billion CNY	24.86%
2017	1.17 Billion CNY	21.72%
2016	963.78 Million CNY	-18.7%
2015	1.18 Billion CNY	4.54%
2014	1.13 Billion CNY	14.2%
2013	993.04 Million CNY	-32.0%
2012	1.46 Billion CNY	17.32%
2011	1.24 Billion CNY	17.01%
2010	1.06 Billion CNY	36.56%
2009	778.95 Million CNY	14.3%
2008	681.5 Million CNY	32.23%
2007	515.39 Million CNY	49.37%
2006	345.04 Million CNY	0.0%

Year	Inventory	Inventory Growth
2024 Q2	2.37 Billion CNY	0.0%
2023 Q2	2.19 Billion CNY	0.0%
2023 Q4	2.23 Billion CNY	0.0%
2023 FY	2.23 Billion CNY	3.46%
2022 Q4	2.16 Billion CNY	0.0%
2022 FY	2.16 Billion CNY	7.96%
2022 Q2	2.21 Billion CNY	0.0%
2021 Q2	1.65 Billion CNY	0.0%
2021 FY	2 Billion CNY	40.29%
2021 Q4	2 Billion CNY	0.0%
2020 Q2	1.53 Billion CNY	0.0%
2020 Q4	1.42 Billion CNY	0.0%
2020 FY	1.42 Billion CNY	-9.31%
2019 Q2	1.52 Billion CNY	0.0%
2019 FY	1.57 Billion CNY	7.55%
2019 Q4	1.57 Billion CNY	0.0%
2018 Q2	1.38 Billion CNY	0.0%
2018 Q4	1.46 Billion CNY	0.0%
2018 FY	1.46 Billion CNY	24.86%
2017 FY	1.17 Billion CNY	21.72%
2017 Q4	1.17 Billion CNY	0.0%
2017 Q2	1.1 Billion CNY	0.0%
2016 Q4	963.78 Million CNY	0.0%
2016 FY	963.78 Million CNY	-18.7%
2016 Q2	1.19 Billion CNY	0.0%
2015 FY	1.18 Billion CNY	4.54%
2015 Q2	1.31 Billion CNY	0.0%
2015 Q4	1.18 Billion CNY	0.0%
2014 Q2	1.36 Billion CNY	0.0%
2014 Q4	1.13 Billion CNY	0.0%
2014 FY	1.13 Billion CNY	14.2%
2013 Q2	1.2 Billion CNY	0.0%
2013 FY	993.04 Million CNY	-32.0%
2013 Q4	993.83 Million CNY	0.0%
2012 Q2	1.21 Billion CNY	0.0%
2012 Q4	1.46 Billion CNY	0.0%
2012 FY	1.46 Billion CNY	17.32%
2011 Q4	1.24 Billion CNY	0.0%
2011 Q2	1.29 Billion CNY	0.0%
2011 FY	1.24 Billion CNY	17.01%
2010 Q4	1.06 Billion CNY	0.0%
2010 FY	1.06 Billion CNY	36.56%
2010 Q2	939.41 Million CNY	0.0%
2009 Q4	778.95 Million CNY	0.0%
2009 FY	778.95 Million CNY	14.3%
2008 FY	681.5 Million CNY	32.23%
2007 FY	515.39 Million CNY	49.37%
2006 FY	345.04 Million CNY	0.0%

Peer Inventory Comparison of The United Laboratories International Holdings Limited

Name	Inventory	Inventory Difference
Pak Fah Yeow International Limited	12.19 Million HKD	-18252.736%
Grand Pharmaceutical Group Limited	1.38 Billion HKD	-61.199%
Extrawell Pharmaceutical Holdings Limited	7.26 Million HKD	-30711.879%
Wai Yuen Tong Medicine Holdings Limited	308.09 Million HKD	-626.549%
Qianhai Health Holdings Limited	431.78 Million HKD	-418.424%
Lee's Pharmaceutical Holdings Limited	298.1 Million HKD	-650.902%
Essex Bio-Technology Limited	62.82 Million HKD	-3463.22%
Tongfang Kontafarma Holdings Limited	98.26 Million HKD	-2177.983%
PuraPharm Corporation Limited	175.59 Million HKD	-1174.784%
SSY Group Limited	1.08 Billion HKD	-106.068%
JBM (Healthcare) Limited	91.58 Million HKD	-2344.159%
Jacobson Pharma Corporation Limited	317.85 Million HKD	-604.242%
China Resources Pharmaceutical Group Limited	35.09 Billion HKD	93.622%